References
  1. Postow MA, Sidlow R, Hellmann MD.Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.N Engl J Med.2018 Jan 11;378(2):158-168.
  2. Johnson DB, Manouchehri A, Haugh AM,et al.Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.J Immunother Cancer.2019 May 22;7(1):134.
  3. Shi Jiayu, Niu Jingwen, Shen Dongchao, et al. Clinical recommendations for diagnosis and treatment of neurological adverse reactions related to immune checkpoint inhibitors [J]. Chinese Journal of Lung Cancer, 2019,22 (10): 633-638.
  4. Ramos-Casals M, Brahmer JR, Callahan MK,et al.Immune-related adverse events of checkpoint inhibitors.Nat Rev Dis Primers.2020 May 7;6(1):38.
  5. Haanen JBAG, Carbonnel F, Robert C, et al; ESMO Guidelines Committee.Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol.2017 Jul 1;28(suppl_4):iv119-iv142.
  6. Kanjanapan Y, Day D, Butler MO, Wang L, et al.Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials.Eur J Cancer.2019 Jan;107:1-7.
  7. Kao JC, Liao B, Markovic SN,et al.Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.JAMA Neurol.2017 Oct 1;74(10):1216-1222.
  8. Sanchis-Borja M, Ricordel C, Chiappa AM,et al.Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort.Lung Cancer.2020 May;143:36-39.
  9. Johnson DB, Manouchehri A, Haugh AM,et al.Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.J Immunother Cancer.2019 May 22;7(1):134.
  10. Neurological Infectious Diseases and Cerebrospinal fluid Cytology Group of Neurology Branch of Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of autoimmune encephalitis (2022 edition) [J]. Chinese Journal of Neurology, 2022,55 (9): 931-949.
  11. Özdirik B, Jost-Brinkmann F, Savic LJ,et al.Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review.Medicine (Baltimore).2021 Jun 18;100(24):e26377.
  12. Schneider S, Potthast S, Komminoth P,et al.PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis.Case Rep Oncol.2017 May 24;10(2):473-478.
  13. Wang Jiawei, Li Yadong. Pathogenesis and diagnosis and treatment of autoimmune encephalitis [J]. Chinese Journal of Neurology, 2022,55 (10): 1148-1153.
  14. Wang DY, Salem JE, Cohen JV,et al.Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.JAMA Oncol.2018 Dec 1;4(12):1721-1728.
  15. Wang Song, Chen Xia. Immune checkpoint inhibitor-related neurological adverse events: from mechanism to therapy [J]. Chinese Journal of Neuroimmunology and Neurology, 2021,28 (01): 61-66.